Bundamedik Tbk PT Capital Reinvestment Ratio
Bundamedik Tbk PT capital reinvestment ratio. Bundamedik Tbk PT (BMHS) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Rp199.64 Billion) in capital expenditures (Rp116.26 Billion). See how much free cash does Bundamedik Tbk PT generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bundamedik Tbk PT (2018–2025)
Capital reinvestment ratio of Bundamedik Tbk PT from 2018 to 2025. This chart tracks Bundamedik Tbk PT's Capital Reinvestment Ratio across 8 annual periods. See Bundamedik Tbk PT (BMHS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Bundamedik Tbk PT Capital Reinvestment Ratio by Year (2018–2025)
Bundamedik Tbk PT capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see Bundamedik Tbk PT (BMHS) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | Rp250.62 Billion | Rp218.91 Billion | ▼ -87.4% |
| 2024 | 6.95x | Rp33.98 Billion | Rp236.03 Billion | ▲ +70.7% |
| 2023 | 4.07x | Rp51.44 Billion | Rp209.35 Billion | ▲ +220.3% |
| 2022 | 1.27x | Rp237.47 Billion | Rp301.73 Billion | ▲ +94.7% |
| 2021 | 0.65x | Rp349.44 Billion | Rp228.08 Billion | ▲ +150.5% |
| 2020 | 0.26x | Rp190.36 Billion | Rp49.61 Billion | ▼ -67.8% |
| 2019 | 0.81x | Rp89.72 Billion | Rp72.50 Billion | ▼ -77.4% |
| 2018 | 3.57x | Rp43.79 Billion | Rp156.54 Billion | — |